NEW YORK, August 12, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Anadarko Petroleum Corporation (NYSE: APC), ConocoPhillips (NYSE: COP), Occidental Petroleum Corporation (NYSE: OXY), The Dow Chemical Company (NYSE: DOW) and Gulfport Energy Corporation (NASDAQ: GPOR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5660-100free.
--
Anadarko Petroleum Corporation Research Reports
On August 4, 2014, Anadarko Petroleum Corporation (Anadarko) reported that its Board of Directors has declared a quarterly cash dividend of $0.27 per share on its common stock. The Company informed that the dividend will be paid on September 24, 2014 to holders of record as on September 10, 2014. Anadarko's recently announced dividend is unchanged from the dividend announced in the previous quarter. The full research reports on Anadarko are available to download free of charge at:
http://www.analystsreview.com/Aug-12-2014/APC/report.pdf
--
ConocoPhillips Research Reports
On July 31, 2014, ConocoPhillips (ConocoPhillips) reported Q2 2014 total revenues and other income of $14.70 billion, up 4.0% YoY. Analysts polled by Thomson Reuters expected the Company to post Q2 2014 EPS of $1.60 on total revenue and other income of $15.38 billion. The Company's Q2 2014 net income attributable to ConocoPhillips common shareholders came in at $2.1 billion or $1.67 per diluted share, compared to net income of $2.1 billion or $1.65 per diluted share in Q2 2013. The Company reported H1 2014 total revenue and other income of $30.7 billion, up 6.8% YoY and net income of $4.2 billion, up 0.4% YoY. For Q3 2014, the Company expects production from continuing operations (excluding Libya) in the range of 1,435 - 1,485 MBOED (Million Barrels Oil Equivalent per Day), while for Q4 2014, the production is expected between 1,590 to 1,640 MBOED. For full-year 2014, the Company expects production from continuing operations (excluding Libya) to be in the range of about 1,525 to 1,550 MBOED. The full research reports on ConocoPhillips are available to download free of charge at:
http://www.analystsreview.com/Aug-12-2014/COP/report.pdf
--
Occidental Petroleum Corporation Research Reports
On July 31, 2014, Occidental Petroleum Corporation (Occidental) reported a 5.2% YoY growth in its Q2 2014 net sales to $6.28 billion, helped by growth in Oil and Gas; Chemical; and Midstream, Marketing and Other segments. During the quarter, the Company's core EPS improved 13.3% YoY to $1.79. According to Zacks, Occidental was expected to post Q2 2014 adjusted EPS of $1.75 on net sales of $5.99 billion. The Company's Q2 2014 net income stood at $1.4 billion or $1.82 per diluted share, compared to net income of $1.3 billion or $1.64 per diluted share in Q2 2013. The Company's H1 2014 net sales improved 4.5% YoY to $12.4 billion, while net income came in at $2.8 billion, compared to net income of $2.7 billion in H1 2013. The full research reports on Occidental are available to download free of charge at:
http://www.analystsreview.com/Aug-12-2014/OXY/report.pdf
--
The Dow Chemical Company Research Reports
On August 7, 2014, The Dow Chemical Company (Dow) reported that CNBC has named the Company on its prestigious list of the top 50 innovation companies in the U.S. Dow announced that the aforementioned prestigious ranking evaluates companies based on their ability to increase revenue from R&D, using a unique formula which takes publicly available information to measures a company's "Research Quotient" or the level of R&D productivity that links R&D spend to revenue growth and market value. Further, Dow is the only chemical Company appearing on this list. A.N. Sreeram, Dow's Corporate Vice President of R&D, said, "Our customers value our partnership and consistently reward us with a seat at the design table, which drives our growth. That's the ultimately the recognition we seek, but it's nice to have this external validation of the return on our research investment." The full research reports on Dow are availableto download free of charge at:
http://www.analystsreview.com/Aug-12-2014/DOW/report.pdf
--
Gulfport Energy Corporation Research Reports
On August 6, 2014, Gulfport Energy Corporation (Gulfport) released its Q2 2014 and H1 2014 financial results. The Company reported Q2 2014 revenues of $114.74 million, up 62.9% YoY. During the quarter, the Company's Oil and condensate sales improved 11.6% YoY to $68.1 million; Gas sales improved 422.9% YoY to $35.5 million; Natural gas liquids sales improved 353.3% YoY to $10.9 million; and other income improved 0.4% YoY to $0.2 million. According to 28 analysts polled by Thomson Reuters, Gulfport was expected to post Q2 2014 EPS of $0.16 (excluding special items) on revenues of $120.54 million. The Company's Q2 2014 net income came in at $47.9 million or $0.56 per diluted share, compared to net income of $43.8 million or $0.56 per diluted share in Q2 2013. The Company's H1 2014 revenues improved 85.6% YoY to $232.8 million, while net income improved 47.5% YoY to $130.4 million. For full-year 2014, the Company expects production in the range of 13.51 - 15.33 MMBOE per day (Million Barrels of Oil Equivalent). The full research reports onGulfportare available to download free of charge at:
http://www.analystsreview.com/Aug-12-2014/GPOR/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
